drugset / Trial / NCT00915837
Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase 1 study will evaluate the safety, tolerability and duration of effect of a helical intravitreal triamcinolone implant for the treatment of diabetic macular edema over a three-year period.
Timeline
- Start
- 2005-06
- Primary completion
- 2009-04
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triamcinolone Acetonide | Other / unclassified | 925 ug | Intravitreal |